Eloxx Pharmaceuticals

(OTC) ELOX

Current Price$0.19

Market Cap$627,100

Since IPO (2017)-100%

5 Year-100%

1 Year+189,900%

1 Month+58%

Eloxx Pharmaceuticals Financials at a Glance

Market Cap

$627,100

Revenue (TTM)

$0.00

Net Income (TTM)

$20.48M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-16697.80 (Low)

Dividend

$0.00

Beta (Volatility)

-16697.80 (Low)

Price

$0.19

Volume

3,444

Open

$0.19

Price

$0.19

Volume

3,444

Open

$0.19

Previous Close

$0.19

Daily Range

$0.13 - $0.19

52-Week Range

$0.13 - $0.75

Dividend

$0.00

Beta (Volatility)

-16697.80 (Low)

Price

$0.19

Volume

3,444

Open

$0.19

Previous Close

$0.19

Daily Range

$0.13 - $0.19

52-Week Range

$0.13 - $0.75

ELOX News

Why Advanced Micro Devices, Ciena, and Eloxx Pharmaceuticals Jumped Today

Dan CaplingerJun 6, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eloxx Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Sumit Aggarwal, MBA

Website

www.eloxxpharma.com

Headquarters

Watertown, MA 02472, US

ELOX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

54%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$627.10K

Shares Outstanding

3.30M

Volume

3.44K

Avg. Volume

6.76K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$6.44M

EBITDA

$6.44M

Operating Cash Flow

$6.33M

Capital Expenditure

$0.00

Free Cash Flow

$6.33M

Cash & ST Invst.

$4.79M

Total Debt

$1.00M

Eloxx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$627.10K

N/A

Market Cap/Employee

$34.84K

N/A

Employees

N/A

Net Income

$3.59M

+52.2%

EBITDA

$3.17M

+53.6%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Net Cash

$3.79M

-35.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.00M

-78.7%

Return on Assets

-1.14%

N/A

Return on Invested Capital

54.07%

N/A

Free Cash Flow

$3.45M

+50.7%

Operating Cash Flow

$3.45M

+50.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NBRVFNabriva Therapeutics plc

NBRVFNabriva Therapeutics plc$0.00+0.00%

OMDDOrmand Industries Inc

OMDDOrmand Industries Inc$0.00+0.00%

NMSCANutrition Management Services Company

NMSCANutrition Management Services Company$0.00+0.00%

BIOCQBiocept, Inc.

BIOCQBiocept, Inc.$0.00+0.00%

HTGMQHTG Molecular Diagnostics, Inc.

HTGMQHTG Molecular Diagnostics, Inc.$0.00+0.00%

MDVLQMedAvail Holdings, Inc.

MDVLQMedAvail Holdings, Inc.$0.00+0.00%

NEXINexImmune, Inc.

NEXINexImmune, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ELOX

What is the current price of Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals is trading at $0.19 per share.

What is the 52-week range for Eloxx Pharmaceuticals?

Over the past 52 weeks, Eloxx Pharmaceuticals has traded between $0.13 and $0.75.

How much debt does Eloxx Pharmaceuticals have?

As of the most recent reporting period, Eloxx Pharmaceuticals reported total debt of $1.00M.

How much cash does Eloxx Pharmaceuticals have on hand?

Eloxx Pharmaceuticals reported $4.79M in cash and cash equivalents in its most recent financial results.

What is Eloxx Pharmaceuticals’s dividend yield?

Eloxx Pharmaceuticals does not currently have a dividend yield.

Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Financials at a Glance

ELOX News

Why Advanced Micro Devices, Ciena, and Eloxx Pharmaceuticals Jumped Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Eloxx Pharmaceuticals

ELOX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Eloxx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ELOX

What is the current price of Eloxx Pharmaceuticals?

What is the 52-week range for Eloxx Pharmaceuticals?

How much debt does Eloxx Pharmaceuticals have?

How much cash does Eloxx Pharmaceuticals have on hand?

What is Eloxx Pharmaceuticals’s dividend yield?

Premium Investing Services